SWOG clinical trial number
SWOG-9411
A Phase III Prospective Randomized Trial Comparing Laparoscopic - Assisted Colectomy Versus Open Colectomy for Colon Cancer
Closed
Phase
Published
Abbreviated Title
COLON
Activated
10/01/1994
Closed
08/31/2001
Research committees
Gastrointestinal Cancer
Treatment
Surgery
Eligibility Criteria Expand/Collapse
Clinical diagnosis of adenocarcinoma of the right, left or sigmoid colon based on physical exam and diagnostic workup with final confirmation by pathology. Contraindications: Advanced local dz rendering laparoscopic resection not possible, stage IV dz, rectal cancer, acutely obstructed or perforated colon requiring urgent surgery, transverse colon cancer, ASA classification IV or V.
Publication Information Expand/Collapse
2002
Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer
Other Clinical Trials
SWOG Clinical Trial Number
CTSU/A022101
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
SWOG Clinical Trial Number
S2107
Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
Accrual
71%
Open
Phase
SWOG Clinical Trial Number
S2104
A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
Research Committee(s)
Gastrointestinal Cancer
Activated
10/14/2021
Accrual
27%
Open
Phase